Corey J Georgesen

Dr. Corey J Georgesen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2024 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
EEEmily Ba Ehsan
Emily Ba Ehsan
EWErin X. Wei
Erin X. Wei
CGCorey J Georgesen
Corey J Georgesen
Importance: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous adverse reaction occurring 2 to 8 weeks after medication initiation. Diagnosis is clinical; RegiSCAR scoring includes biopsy “suggestive of DRESS,” undefined in the literature. Objective: This study correlates DRESS dermatopathology, culprit drugs, disease course, and outcome severity compared with maculopapular drug reactions (MDR). Methods: Between 2014 and 2023, a retrospective cohort study at a tertiary care institute reviewed 55 patients with DRESS, assessing demographics, culprit drug, illness course, and histopathology. Biopsies of 15 patients with DRESS and 15 MDR patients were graded by a predefined histopathological scoring system. Statistical analysis (significant P-value<0.05) included the Fisher exact probability, ANOVA, and correlation tests. Results: Among 55 patients with DRESS (mean age 50.13, 28 female/27 male), 15 (mean age 50.4, 7 female/8 male) had diagnostic biopsies. Compared with MDR patients, patients with DRESS exhibited significantly more interface dermatitis (P = 0.04), lichenoid dermatitis (P = 0.0007), pigment incontinence (P = 0.04), and periadnexal interface dermatitis (P = 0.002). MDR biopsies displayed perivascular inflammation and higher eosinophils than DRESS, trending toward significance. Conclusions: Key histopathologic features are interface dermatitis, periadnexal interface dermatitis, lichenoid dermatitis, pigment incontinence, and neutrophils dominance over eosinophils indicate DRESS clinically.

3 July 2022 in JAAD Case Reports
Verified
Journal Article
Open access
PWPaul Wurtz
Paul Wurtz
RBRobert Borucki
Robert Borucki
CGCorey J Georgesen
Corey J Georgesen

15 August 2023 in Cureus
Verified
Journal Article
Open access
PDF file
ELErica Lee
Erica Lee
AWAshley Wysong
Ashley Wysong
CRCamilla S. Reimer
Camilla S. Reimer
CGCorey J Georgesen
Corey J Georgesen
Background: Dermatologic disease has been shown to have high rates of diagnostic and treatment discordance between dermatologists and non-specialists. Inpatient dermatology consultative services have the potential to improve patient care, but there is a paucity of data evaluating the quantitative effects of such services. This study aimed to evaluate the impact a newly established inpatient dermatology service had on quantitative patient care outcomes. Methods: This retrospective cohort study compared quantitative care measures of dermatologic inpatients during the years both pre- and post-implementation of an academic hospital’s dermatology consultative service. The primary outcomes included hospitalization duration, readmission rates, and establishment of outpatient dermatologic care. Results: The study found a 1.04-day reduction in hospital length of stay (p-value = 0.046) after the consultation service establishment. Additionally, there was a significant increase in the rate by which patients sought outpatient dermatology follow-up (6.7% versus 24.4%, p-value <0.001). No significant change in the all-cause readmission rate was identified. Conclusion: The reduction of hospitalization duration supports inpatient dermatology services as a viable means to provide improved patient care and reduce health systems costs. Hospitals that do not have a consulting service for cutaneous conditions provided by a dermatology specialist should strongly consider establishing such a department.

1 June 2022 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
TTTaylor Bs Thieman
Taylor Bs Thieman
RSRitu Swali
Ritu Swali
DCDillon Clarey
Dillon Clarey
TETyler Evans
Tyler Evans
ELErica Lee
Erica Lee
CGCorey J Georgesen
Corey J Georgesen

1 June 2022 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
TTTaylor Bs Thieman
Taylor Bs Thieman
RSRitu Swali
Ritu Swali
DCDillon Clarey
Dillon Clarey
TETyler Evans
Tyler Evans
ELErica Lee
Erica Lee
CGCorey J Georgesen
Corey J Georgesen

31 December 2025 in Dermatopathology
Verified
Journal Article
Open access
PDF file
CSCalla Sullivan
Calla Sullivan
DDDominick DiMaio
Dominick DiMaio
LLLauer R Lauer
Lauer R Lauer
Dinesh PradhanDinesh Pradhan
Dinesh Pradhan
JYJulie Youngs
Julie Youngs
CGCorey J Georgesen
Corey J Georgesen
Accurate diagnosis of melanomas is crucial for proper evaluation and treatment. One immunohistochemical stain frequently utilized is PRAME (PReferentially expressed Antigen in MElanoma), a tumor-associated antigen expressed in most melanomas. This study aims to evaluate the reproducibility of PRAME scoring performed by dermatopathologists at an academic tertiary referral medical center. A blinded survey was designed featuring 21 melanocytic neoplasms stained with PRAME and H&E. For each case, five dermatopathologists provided a PRAME score from 0–4+, percent PRAME positivity, values for H-score, and a descriptive interpretation. Absolute agreement across raters was assessed using a Kappa statistic for PRAME score and intraclass correlations (ICCs) for H-score and PRAME percentage. Statistical analysis indicated poor inter-rater reliability for PRAME score (Kappa = 0.16), percent PRAME positivity (ICC = 0.31), and H-score (ICC = 0.40). Reporting language varied among pathologists. Our study demonstrated that the interpretation of PRAME immunohistochemistry lacks reproducibility, especially for challenging lesions. This suggests that a more rigorous, defined, and reproducible scoring method should be investigated for equivocal cases. Future studies may explore the utility of artificial intelligence software in the interpretation of PRAME for borderline lesions to improve reliability and standardize scoring.